AGMThis should be a very interesting AGM. the things i hope to hear are:
1. The Dermal Injector testing has been completed and is ready for submission to the FDA. Mainpointe has completed it's roll-out strategy for the U.S. Also Yofoto is ready to market the device in China once the FDA approves the device.
2. Update on the Shiseido Arbitration. Has Replicel reached out to Shiseido to discuss a possible
deal where the two companies work together to bring RCH-01 to market. Another possibility is there any discussion between the 2 companies regarding a possible buy out of Replicel. Thirdly there is no news and the two companies are preparing for the hearing in late May.
3. What are the future plans for RCS-01 and RCT-01.